TABLE 1. GLOBAL WOMENS HEALTH DIAGNOSTICS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. WOMENS HEALTH DIAGNOSTIC DEVICES MARKET, BY DEVICE TYPE, 2016-2023 ($MILLION)
TABLE 3. WOMENS HEALTH DIAGNOSTIC DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. BIOPSY DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. IMAGING AND MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 6. IMAGING AND MONITORING SYSTEMS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. ULTRASOUND SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 8. ULTRASOUND SYSTEMS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. MAMMOGRAPHY SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 10. MAMMOGRAPHY SYSTEMS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 11. MRI SYSTEMS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. NUCLEAR IMAGING SYSTEMS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 13. WOMENS HEALTH DIAGNOSTIC TESTS MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 14. WOMENS HEALTH DIAGNOSTIC TESTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. BREAST CANCER TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 16. BREAST CANCER TESTING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. HORMONE RECEPTOR TEST MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 18. IMMUNOHISTOCHEMISTRY (IHC) TEST MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. OTHER BREAST CANCER TESTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. CERVICAL CANCER TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 21. CERVICAL CANCER TESTING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. PAP TEST MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. HPV TEST MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 24. PRENATAL GENETIC SCREENING & CARRIER TESTING MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 25. PRENATAL GENETIC SCREENING & CARRIER TESTING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 26. PRENATAL GENETIC SCREENING & CARRIER TESTING MARKET FOR CYSTIC FIBROSIS, BY REGION, 2016-2023 ($MILLION)
TABLE 27. PRENATAL GENETIC SCREENING & CARRIER TESTING MARKET FOR OTHER DISEASES, BY REGION, 2016-2023 ($MILLION)
TABLE 28. PREGNANCY & OVULATION TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 29. PREGNANCY & OVULATION TESTING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 30. LAB-BASED PREGNANCY & OVULATION TESTING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 31. HOME-BASED PREGNANCY & OVULATION TESTING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 32. OVARIAN CANCER TESTING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 33. WOMENS HEALTH DIAGNOSTICS MARKET FOR ACCESSORIES & CONSUMABLES, BY REGION, 2016-2023 ($MILLION)
TABLE 34. GLOBAL WOMENS HEALTH DIAGNOSTICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 35. WOMENS HEALTH DIAGNOSTICS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 36. WOMENS HEALTH DIAGNOSTICS MARKET FOR HOME CARE SETTING, BY REGION, 2016-2023 ($MILLION)
TABLE 37. WOMENS HEALTH DIAGNOSTICS MARKET FOR DIAGNOSTICS & IMAGING CENTERS, BY REGION, 2016-2023 ($MILLION)
TABLE 38. WOMENS HEALTH DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2016-2023 ($MILLION)
TABLE 39. WOMENS HEALTH DIAGNOSTICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 40. NORTH AMERICA WOMENS HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 41. NORTH AMERICA WOMENS HEALTH DIAGNOSTICS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 42. NORTH AMERICA WOMENS HEALTH DIAGNOSTIC DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 43. NORTH AMERICA IMAGING AND MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 44. NORTH AMERICA ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 45. NORTH AMERICA MAMMOGRAPHY SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 46. NORTH AMERICA WOMEN'S HEALTH DIAGNOSTICS TEST MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 47. NORTH AMERICA BREAST CANCER TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 48. NORTH AMERICA CERVICAL CANCER TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 49. NORTH AMERICA PRENATAL GENETIC SCREENING & CARRIER TESTING MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 50. NORTH AMERICA PREGNANCY & OVULATION TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 51. NORTH AMERICA WOMENS HEALTH DIAGNOSTICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 52. TOP 10 COUNTRIES IN EUROPE WITH OVARIAN CANCER INCIDENCE AND MORTALITY, 2012
TABLE 53. EUROPE WOMENS HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 54. EUROPE WOMENS HEALTH DIAGNOSTICS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 55. EUROPE WOMENS HEALTH DIAGNOSTIC DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 56. EUROPE IMAGING AND MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 57. EUROPE ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 58. EUROPE MAMMOGRAPHY SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 59. EUROPE WOMEN'S HEALTH DIAGNOSTICS TEST MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 60. EUROPE BREAST CANCER TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 61. EUROPE CERVICAL CANCER TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 62. EUROPE PRENATAL GENETIC SCREENING & CARRIER TESTING MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 63. EUROPE PREGNANCY & OVULATION TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 64. EUROPE WOMENS HEALTH DIAGNOSTICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 65. ASIA-PACIFIC WOMENS HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 66. ASIA-PACIFIC WOMENS HEALTH DIAGNOSTICS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 67. ASIA-PACIFIC WOMENS HEALTH DIAGNOSTIC DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 68. ASIA-PACIFIC IMAGING AND MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 69. ASIA-PACIFIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 70. ASIA-PACIFIC MAMMOGRAPHY SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 71. ASIA-PACIFIC WOMEN'S HEALTH DIAGNOSTICS TEST MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 72. ASIA-PACIFIC BREAST CANCER TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 73. ASIA-PACIFIC CERVICAL CANCER TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 74. ASIA-PACIFIC PRENATAL GENETIC SCREENING & CARRIER TESTING MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 75. ASIA-PACIFIC PREGNANCY & OVULATION TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 76. ASIA-PACIFIC WOMENS HEALTH DIAGNOSTICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 77. LAMEA WOMENS HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 78. LAMEA WOMENS HEALTH DIAGNOSTICS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 79. LAMEA WOMENS HEALTH DIAGNOSTIC DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 80. LAMEA IMAGING AND MONITORING SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 81. LAMEA ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 82. LAMEA MAMMOGRAPHY SYSTEMS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 83. LAMEA WOMEN'S HEALTH DIAGNOSTICS TEST MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 84. LAMEA BREAST CANCER TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 85. LAMEA CERVICAL CANCER TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 86. LAMEA PRENATAL GENETIC SCREENING & CARRIER TESTING MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 87. LAMEA PREGNANCY & OVULATION TESTING MARKET, BY TEST TYPE, 2016-2023 ($MILLION)
TABLE 88. LAMEA WOMENS HEALTH DIAGNOSTICS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 89. ABBOTT: COMPANY SNAPSHOT
TABLE 90. ABBOTT: OPERATING SEGMENTS
TABLE 91. BD: COMPANY SNAPSHOT
TABLE 92. BD: OPERATING SEGMENTS
TABLE 93. BD: PRODUCT PORTFOLIO
TABLE 94. CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 95. CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 96. CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 97. CARESTREAM: COMPANY SNAPSHOT
TABLE 98. CARESTREAM: OPERATING SEGMENTS
TABLE 99. CARESTREAM: PRODUCT PORTFOLIO
TABLE 100. COOK: COMPANY SNAPSHOT
TABLE 101. COOK: OPERATING SEGMENTS
TABLE 102. COOK: PRODUCT PORTFOLIO
TABLE 103. C. R. BARD: COMPANY SNAPSHOT
TABLE 104. C. R. BARD: OPERATING SEGMENTS
TABLE 105. C. R. BARD: PRODUCT PORTFOLIO
TABLE 106. ROCHE: COMPANY SNAPSHOT
TABLE 107. ROCHE: OPERATING SEGMENTS
TABLE 108. ROCHE: PRODUCT PORTFOLIO
TABLE 109. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 110. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 111. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 112. HOLOGIC: COMPANY SNAPSHOT
TABLE 113. HOLOGIC: OPERATING SEGMENTS
TABLE 114. HOLOGIC: PRODUCT PORTFOLIO
TABLE 115. PHILIPS: COMPANY SNAPSHOT
TABLE 116. PHILIPS: OPERATING SEGMENTS
TABLE 117. PHILIPS: PRODUCT PORTFOLIO
TABLE 118. MEDGYN: COMPANY SNAPSHOT
TABLE 119. MEDGYN: PRODUCT PORTFOLIO
TABLE 120. QUEST DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 121. QUEST DIAGNOSTICS: OPERATING SEGMENTS
TABLE 122. QUEST DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 123. SIEMENS: COMPANY SNAPSHOT
TABLE 124. SIEMENS: OPERATING SEGMENTS
TABLE 125. SIEMENS: PRODUCT PORTFOLIO
TABLE 126. THERMO FISHER: COMPANY SNAPSHOT
TABLE 127. THERMO FISHER: OPERATING SEGMENTS
TABLE 128. THERMO FISHER: PRODUCT PORTFOLIO

LIST OF FIGURE

FIGURE 1. WOMENS HEALTH DIAGNOSTICS MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. DISTRIBUTION OF ESTIMATED BREAST CANCER CASES ACROSS THE WORLD, 2012 (%)
FIGURE 4. IMPACT ANALYSIS, 2016
FIGURE 5. GLOBAL WOMENS HEALTH DIAGNOSTICS MARKET, BY TYPE, 2016-2023
FIGURE 6. OB/GYN ULTRASOUND DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 7. BREAST ULTRASOUND DEVICES MARKET, 2016-2023 ($MILLION)
FIGURE 8. ANALOG MAMMOGRAPHY SYSTEMS MARKET, 2016-2023 ($MILLION)
FIGURE 9. DIGITAL MAMMOGRAPHY SYSTEMS MARKET, 2016-2023 ($MILLION)
FIGURE 10. BREAST TOMOSYNTHESIS MARKET, 2016-2023 ($MILLION)
FIGURE 11. PERCENTAGE OF BREAST CANCER BY AGE GROUP, 2010-2014
FIGURE 12. GLOBAL WOMENS HEALTH DIAGNOSTICS MARKET, BY END USER, 2016-2023
FIGURE 13. ESTIMATED NUMBER OF BREAST CANCER CASES, BY REGION, 2012 (POPULATION IN PERCENTAGE)
FIGURE 14. NORTH AMERICA WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023
FIGURE 15. ESTIMATED CASES OF INVASIVE BREAST CANCER IN U.S., 2015
FIGURE 16. U.S. WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 17. CANADA WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 18. MEXICO WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 19. EUROPE WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023
FIGURE 20. GERMANY WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 21. FRANCE WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 22. UK WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 23. ITALY WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 24. SPAIN WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 25. REST OF EUROPE WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 26. ASIA-PACIFIC WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023
FIGURE 27. INCIDENCE RATES OF CERVICAL CANCER IN REGIONS OF ASIA IN 2012, BY COUNTRY
FIGURE 28. CHINA WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 29. JAPAN WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 30. INDIA WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 31. AUSTRALIA WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 32. SOUTH KOREA WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 33. REST OF ASIA-PACIFIC WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 34. LAMEA WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023
FIGURE 35. BRAZIL WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 36. SAUDI ARABIA WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 37. SOUTH AFRICA WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 38. REST OF LAMEA WOMENS HEALTH DIAGNOSTICS MARKET, 2016-2023 ($MILLION)
FIGURE 39. ABBOTT: NET SALES, 2014-2016 ($MILLION)
FIGURE 40. ABBOTT: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 41. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 42. BD: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. BD: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 44. BD: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 45. CARDINAL HEALTH: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. CARDINAL HEALTH: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 47. C. R. BARD: NET SALES, 2014-2016 ($MILLION)
FIGURE 48. C. R. BARD: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 49. C. R. BARD: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 50. ROCHE: NET SALES, 2014-2016 ($MILLION)
FIGURE 51. ROCHE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 52. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 53. GE HEALTHCARE: NET SALES, 2014-2016 ($MILLION)
FIGURE 54. GE HEALTHCARE: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 55. GE HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 56. HOLOGIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 57. HOLOGIC: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 58. HOLOGIC: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 59. PHILIPS: NET SALES, 2014-2016 ($MILLION)
FIGURE 60. PHILIPS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 61. PHILIPS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 62. QUEST DIAGNOSTICS: NET SALES, 2014-2016 ($MILLION)
FIGURE 63. QUEST DIAGNOSTICS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 64. SIEMENS: NET SALES, 2015-2017 ($MILLION)
FIGURE 65. SIEMENS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 66. SIEMENS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 67. THERMO FISHER: NET SALES, 2014-2016 ($MILLION)
FIGURE 68. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 69. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)